A Novel lncRNA, CTD-2017C7.1, Promotes ESCC Tumorigenesis by Binding to PDIA3 and Activating Oncogenic Gene Expressions
Abstract BackgroundlncRNAs are dysregulated in many human cancers, including esophageal squamous cell carcinoma (ESCC), and are associated cancer development and progression. In the current study, we aimed to elucidate the biological roles of lncRNA CTD-2017C7.1 in ESCC. MethodThe biological functions of CTD-2017C7.1 were determined in vitro and in vivo. RNA pull-down, MS, RIP, RNA-seq, and qRT-PCR assays were employed to investigate the mechanisms of CTD-2017C7.1. ResultsCTD-2017C7.1 was up-regulated in ESCC tissues and cells, and associated with poor clinical outcome. Overexpression of CTD-2017C7.1 promoted cell proliferation, invasion and migration. CRISPR/Cas9 knockout of CTD-2017C7.1 resulted in reverse effects. Up-regulation of CTD-2017C7.1 also increased ESCC tumor growth in vivo. Mechanistically, CTD-2017C7.1 bound to PDIA3 and activated the expressions of oncogenic genes. ConclusionOur study revealed that CTD-2017C7.1 was an oncogenic lncRNA that may be a potential therapeutic target of ESCC.